Publications

Found 7 results
Filters: Author is Wogan, Gerald N  [Clear All Filters]
2017
Chawanthayatham S, Valentine CC, Fedeles BI, Fox EJ, Loeb LA, Levine SS, Slocum SL, Wogan GN, Croy RG, Essigmann JM. Mutational spectra of aflatoxin B1 in vivo establish biomarkers of exposure for human hepatocellular carcinoma. PNAS [Internet]. 2017 ;114(15):E3101-E3109. Available from: http://www.pnas.org/content/early/2017/03/27/1700759114?tab=ds
2015
Techapiesancharoenkij N, Fiala JLA, Navasumrit P, Croy RG, Wogan GN, Groopman JD, Ruchirawat M, Essigmann JM. Sulforaphane, a cancer chemopreventive agent, induces pathways associated with membrane biosynthesis in response to tissue damage by aflatoxin B1. Toxicol Appl Pharmacol. 2015 ;282(1):52-60.
2014
Chawanthayatham S, Thiantanawat A, Egner PA, Groopman JD, Wogan GN, Croy RG, Essigmann JM. Prenatal exposure of mice to the human liver carcinogen aflatoxin B1 reveals a critical window of susceptibility to genetic change. Int J Cancer. 2014 .
2012
Wattanawaraporn R, Kim MYoung, Adams J, Trudel LJ, Woo LL, Croy RG, Essigmann JM, Wogan GN. AFB(1) -induced mutagenesis of the gpt gene in AS52 cells. Environ Mol Mutagen. 2012 ;53(7):567-73.
Wattanawaraporn R, Woo LL, Belanger C, Chang S-C, Adams JE, Trudel LJ, Bouhenguel JT, Egner PA, Groopman JD, Croy RG, et al. A single neonatal exposure to aflatoxin b1 induces prolonged genetic damage in two loci of mouse liver. Toxicol Sci. 2012 ;128(2):326-33.
2011
Woo LL, Egner PA, Belanger CL, Wattanawaraporn R, Trudel LJ, Croy RG, Groopman JD, Essigmann JM, Wogan GN, Bouhenguel JT. Aflatoxin B1-DNA adduct formation and mutagenicity in livers of neonatal male and female B6C3F1 mice. Toxicol Sci. 2011 ;122(1):38-44.
Fiala JLA, Egner PA, Wiriyachan N, Ruchirawat M, Kensler KH, Wogan GN, Groopman JD, Croy RG, Essigmann JM. Sulforaphane-mediated reduction of aflatoxin B₁-N⁷-guanine in rat liver DNA: impacts of strain and sex. Toxicol Sci. 2011 ;121(1):57-62.